AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES

As filed

Subsection

03

NTEE code

G400

Classification

2000

Street

1001 N FAIRFAX ST STE 400

These codes are the IRS's own and are shown exactly as filed. What each one means is in the Business Master File documentation (opens in a new tab).

Other organizations at this address

1 other organization in the IRS Business Master File lists the same street address. matched by us

This address is a suite or unit (STE 400). Organizations that share one are often clients of the same office-services firm, accountant or registered agent rather than related to each other.

We match the street line and ZIP code as the IRS gives them, ignoring case and outer spaces and nothing else, so "AVE" and "AVENUE" count as different streets and this list can miss some. A shared address can mean related organizations or a shared office, but it can also be a registered agent, a mail drop or a service provider holding mail for unrelated clients. It is not, by itself, evidence that two organizations are connected.

• AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION

  EIN 46-4495751

Mission and programs · 2024

• MEETINGS AND EDUCATION, INCLUDING THE LIVER MEETING: AASLD'S DYNAMIC EDUCATIONAL PROGRAMS PROVIDE HEALTHCARE PROFESSIONALS CUTTING-EDGE ADVANCEMENTS IN SCIENCE AND INNOVATIVE NEW TECHNIQUES TO ADVANCE HEPATOLOGY TRAINING AND PROFESSIONAL DEVELOPMENT THROUGH IMMERSIVE FACE-TO-FACE EVENTS AND ROBUST ONLINE LEARNING PLATFORMS. THESE INITIATIVES FOSTER THE EXCHANGE OF GROUNDBREAKING RESEARCH, ELEVATE PATIENT CARE, AND SPARK NEW DISCOVERIES IN LIVER DISEASE MANAGEMENT. THE LIVER MEETING, AASLD'S PREMIER ANNUAL EVENT, IS A GLOBAL CORNERSTONE FOR THE FIELD OF HEPATOLOGY, SHOWCASING TRANSFORMATIVE RESEARCH AND TREATMENT OUTCOMES. ATTENDEES ENGAGE IN PLENARY AND PARALLEL SESSIONS, POSTER PRESENTATIONS, STATE-OF-THE-ART LECTURES, MEET-THE-EXPERT SESSIONS, SPECIALTY COURSES, AND SPECIAL INTEREST GROUP PROGRAMMING FOSTERING COLLABORATION AND KNOWLEDGE-SHARING AMONG LEADING EXPERTS AND PRACTITIONERS. ADDITIONALLY, AASLD HOSTS FOCUSED STAND-ALONE EVENTS LIKE THE EMERGING TOPIC CONFERENCES, CO-SPONSORS DIGESTIVE DISEASE WEEK, AND PARTNERS WITH DOMESTIC AND INTERNATIONAL MEDICAL SOCIETIES, GOVERNMENT ENTITIES, AND NONPROFIT ORGANIZATIONS TO DELIVER IMPACTFUL EDUCATIONAL PROGRAMMING IN HEPATOLOGY.AASLD'S ONLINE LEARNING ECOSYSTEM, ANCHORED BY LIVERLEARNING, THE OFFICIAL E-LEARNING PORTAL, OFFERS ON-DEMAND WEBINARS ORGANIZED BY SPECIAL INTEREST GROUPS, PROVIDING IN-DEPTH EXPLORATION OF SPECIALIZED TOPICS. LIVERLEARNING SERVES AS A COMPREHENSIVE DIGITAL REPOSITORY, HOUSING CONTENT FROM AASLD MEETINGS, PRACTICE GUIDELINES, SLIDE COMPILATIONS, AND COURSE HANDOUTS, ENABLING HEALTHCARE PROVIDERS TO SEAMLESSLY APPLY THE LATEST MEDICAL KNOWLEDGE TO CLINICAL PRACTICE. THE ORGANIZATION ALSO SUPPORTS ONLINE CONTENT THROUGH SIGNAL PLATFORM SPECIFICALLY DESIGNED FOR OUR SPECIAL INTEREST GROUPS. AASLD IS ACCREDITED BY THE ACCREDITATION COUNCIL FOR CONTINUING MEDICAL EDUCATION (ACCME) TO PROVIDE AMA PRA CATEGORY 1 CREDITS FOR PHYSICIANS. ADDITIONALLY, AASLD OFFERS MAINTENANCE OF CERTIFICATION (MOC) POINTS, AWARDED UPON SUCCESSFUL COMPLETION OF DESIGNATED CME PROGRAMS, WITH MOC ULTIMATELY GRANTED BY THE AMERICAN BOARD OF INTERNAL MEDICINE OR AMERICAN BOARD OF PEDIATRICS.

  Expenses $9,743,304 · Grants $4,500 · Revenue $8,794,501

• PUBLICATIONS: AASLD'S JOURNALS, HEPATOLOGY, LIVER TRANSPLANTATION, AND HEPATOLOGY COMMUNICATIONS DELIVER PEER-REVIEWED, HIGH-IMPACT RESEARCH ON LIVER AND BILIARY TRACT DISEASES, SETTING THE STANDARD FOR SCIENTIFIC EXCELLENCE IN THE FIELD. AASLD'S FLAGSHIP JOURNAL, HEPATOLOGY, PUBLISHES ORIGINAL, PEER-REVIEWED ARTICLES CONCERNING ALL ASPECTS OF LIVER STRUCTURE, FUNCTION AND DISEASE. EACH MONTH, THE DISTINGUISHED EDITORIAL BOARD MONITORS AND SELECTS ONLY THE BEST ARTICLES ON SUBJECTS SUCH AS IMMUNOLOGY, CHRONIC HEPATITIS, VIRAL HEPATITIS, CIRRHOSIS, GENETIC AND METABOLIC LIVER DISEASES AND THEIR COMPLICATIONS, LIVER CANCER, AND DRUG METABOLISM. LIVER TRANSPLANTATION PUBLISHES CUTTING EDGE SCIENTIFIC BREAKTRLIVER TRANSPLANTATION, A SPECIALIZED JOURNAL, PROVIDES AUTHORITATIVE INSIGHTS INTO THE LATEST ADVANCEMENTS IN LIVER TRANSPLANTATION. HEPATOLOGY COMMUNICATIONS, AN OPEN-ACCESS, PEER-REVIEWED JOURNAL, ENSURES RAPID DISSEMINATION OF HIGH-QUALITY BASIC, TRANSLATIONAL, AND CLINICAL RESEARCH, AMPLIFYING AASLD'S COMMITMENT TO ADVANCING HEPATOLOGY WORLDWIDE.PROFESSIONAL RELATIONS: AASLD'S PROFESSIONAL RELATIONS INITIATIVES STRENGTHEN THE HEPATOLOGY COMMUNITY THROUGH:1. AASLD PRACTICE GUIDELINES: EVIDENCE-BASED RECOMMENDATIONS GROUNDED IN RIGOROUS SCIENTIFIC RESEARCH TO GUIDE PRACTITIONERS AND PATIENTS IN MAKING INFORMED HEALTHCARE DECISIONS FOR SPECIFIC CLINICAL SCENARIOS.2. PRACTICE METRICS COMMITTEE: THIS COMMITTEE DEVELOPS AND REFINES PERFORMANCE MEASURES TO EVALUATE AND ENHANCE THE QUALITY OF CARE FOR LIVER DISEASE PATIENTS FROM BOTH PROVIDER AND PATIENT PERSPECTIVES. IT DRIVES QUALITY IMPROVEMENT INITIATIVES, SUCH AS THE CIRRHOSIS QUALITY COLLABORATIVE (CQC), AND COLLABORATES WITH OTHER AASLD COMMITTEES AND SPECIALTY SOCIETIES TO ADVANCE PATIENT SAFETY AND CARE STANDARDS.3. RELATED SOCIETY COLLABORATIONS: AASLD FOSTERS PARTNERSHIPS WITH DOMESTIC AND INTERNATIONAL MEDICAL SOCIETIES TO ADVANCE HEPATOLOGY THROUGH SHARED PROGRAMS AND ACTIVITIES. MEMBER REPRESENTATIVES ADVOCATE FOR AASLD'S MISSION AT GLOBAL MEETINGS, CREATING PROGRAMS THAT RESONATE WITH AUDIENCES INTERESTED IN MUTUAL TOPICS.4. PATIENT ENGAGEMENT: AASLD IS DEDICATED TO DEEPENING PATIENT CONNECTIONS BY INCREASING PATIENT REPRESENTATION IN ITS ACTIVITIES, ENHANCING ACCESS TO EXPERT RESOURCES, AND BUILDING ROBUST ADVOCACY PARTNERSHIPS TO AMPLIFY THE PATIENT VOICE IN HEPATOLOGY.CLINICAL AND PUBLIC POLICY: AASLD'S PUBLIC POLICY COMMITTEE LEADS A ROBUST ADVOCACY PROGRAM, HOSTING TWO KEY ANNUAL EVENTS: - LIVER CAPITOL HILL DAY: IN PARTNERSHIP WITH PATIENT ADVOCACY ORGANIZATIONS, AASLD EDUCATES CONGRESSIONAL LEGISLATORS AND STAFF ON CRITICAL ISSUES IN LIVER DISEASE RESEARCH AND PATIENT CARE, DRIVING POLICY CHANGE.- FEDERAL AGENCY DAY: AASLD ENGAGES WITH FEDERAL AGENCY PARTNERS TO ALIGN THE SCIENTIFIC COMMUNITY WITH FEDERAL RESEARCH PRIORITIES, FOSTERING COLLABORATION AND INNOVATION.AASLD ENSURES ITS MEMBERS STAY INFORMED ON LEGISLATIVE AND AGENCY DECISIONS IMPACTING HEPATOLOGY, ENCOURAGING ACTIVE PARTICIPATION IN PUBLIC POLICY ADVOCACY.

  Expenses $5,929,583 · Grants $1,208,397 · Revenue $1,279,000

• MEMBERSHIP & MENTORSHIP: AASLD'S VIBRANT MEMBERSHIP OF OVER 7,000 PROFESSIONALSSPANNING PHYSICIANS, SCIENTISTS, HEPATOLOGISTS, SURGEONS, PATHOLOGISTS, STUDENTS, AND ALLIED HEALTH EXPERTSDRIVES HEPATOBILIARY RESEARCH AND PATIENT CARE WORLDWIDE. THE AASLD MENTORSHIP PROGRAM INSPIRES AND NURTURES THE NEXT GENERATION OF HEPATOLOGISTS BY PAIRING MEDICAL, SURGICAL, AND PEDIATRIC RESIDENTS, FELLOWS, AND EARLY-CAREER PROFESSIONALS WITH SEASONED MENTORS. THIS PROGRAM ENSURES A LEGACY OF SKILLED, KNOWLEDGEABLE HEPATOLOGISTS DEDICATED TO ACADEMIC MEDICINE AND PATIENT CARE.WEBSITE: AASLD'S WEBSITES (WWW.AASLD.ORG AND HCVGUIDELINES.ORG) SERVE AS A VITAL HUB FOR MEMBERS, SCIENTISTS, PHYSICIANS, ALLIED HEALTH PROFESSIONALS, AND THE PUBLIC, OFFERING SEAMLESS ACCESS TO CUTTING-EDGE HEPATOLOGY RESOURCES. WITH OVER 2.1 MILLION ANNUAL VISITORS, THE SITE FACILITATES EXPLORATION OF RESEARCH, EDUCATIONAL OFFERINGS, AND PROFESSIONAL OPPORTUNITIES IN HEPATOLOGY.COMMUNICATIONSAASLD KEEPS ITS COMMUNITY INFORMED THROUGH THE BIWEEKLY AASLD E-NEWS, DELIVERING UPDATES ON RESEARCH, MILESTONES, AND POLICY DEVELOPMENTS TO MEMBERS. THE ASSOCIATION ALSO AMPLIFIES ITS IMPACT THROUGH STRATEGIC MEDIA RELATIONS, SPOTLIGHTING GROUNDBREAKING RESEARCH FROM THE LIVER MEETING AND ADVOCATING FOR ADVANCES IN LIVER DISEASE TREATMENT AND PATIENT CARE.

  Expenses $2,141,064 · Grants $110,000 · Revenue $1,916,505

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Officers and directors · 2024

As listed in Part VII of the 2024 return, in the order the filer printed them. Each return names its own; this is not a roster the organization keeps with us.

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us. Earlier years are each on their own filing page.

Filings

• 2024

  Revenue

  $18,281,444

  Expenses

  $20,311,953

  Contributions

  $3,492,285

  Grants paid

  $1,322,897

• 2023

  Revenue

  $15,925,326

  Expenses

  $18,577,313

  Contributions

  $2,345,143

  Grants paid

  $1,259,118

• 2022

  Revenue

  $16,078,688

  Expenses

  $19,046,321

  Contributions

  $2,694,430

  Grants paid

  $1,257,571

The four totals the IRS asks for on Part I of the Form 990, as filed. A dash means the figure was not present on the return — not that it was zero.

Other returns filed

• 2024 · 990-T

  Revenue

  — not reported

  Expenses

  — not reported

  Assets (EOY)

  — not reported

• 2023 · 990-T

  Revenue

  — not reported

  Expenses

  — not reported

  Assets (EOY)

  — not reported

• 2022 · 990-T

  Revenue

  — not reported

  Expenses

  — not reported

  Assets (EOY)

  — not reported

• 2021 · 990

  Revenue

  $8,439,460

  Expenses

  $15,175,180

  Assets (EOY)

  $35,081,762

• 2021 · 990-T

  Revenue

  — not reported

  Expenses

  — not reported

  Assets (EOY)

  — not reported

• 2020 · 990

  Revenue

  $14,513,598

  Expenses

  $12,183,550

  Assets (EOY)

  $42,394,196

• 2020 · 990-T

  Revenue

  — not reported

  Expenses

  — not reported

  Assets (EOY)

  — not reported

• 2019 · 990

  Revenue

  $14,665,136

  Expenses

  $16,032,765

  Assets (EOY)

  $35,678,711

• 2018 · 990

  Revenue

  $15,226,783

  Expenses

  $16,893,325

  Assets (EOY)

  $36,780,872

• 2017 · 990

  Revenue

  $15,189,144

  Expenses

  $15,607,184

  Assets (EOY)

  $38,760,970

Nonprofiteer parses Forms 990, 990-EZ and 990-PF, in a window of recent tax years. These returns are recorded from the IRS e-file index, so their figures were extracted by that index rather than read from the return here — treat them as a different source from the filings above, not as more of the same record. A dash means the index carries no figure; Form 990-T listings carry none at all. Showing the 10 most recent; the API carries the rest.

Grants made

• AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION

  $1,208,397

  2024 · INVEST IN INNOVATIVE HEPATOLOGY RESEARCH AND IN THE PEOPLE WHO STUDY AND TREAT LIVER DISEASE, PROVIDE FUNDING FOR EMERGING LIVER SCHOLAR TRAVEL STIPENDS, PROVIDE FUNDING FOR TRAVEL AWARDS EXPENSES

• AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION

  $1,197,000

  2023 · INVEST IN INNOVATIVE HEPATOLOGY RESEARCH AND IN THE PEOPLE WHO STUDY AND TREAT LIVER DISEASE, PROVIDE FUNDING FOR EMERGING LIVER SCHOLAR TRAVEL STIPENDS, PROVIDE FUNDING FOR TRAVEL AWARDS EXPENSES

• AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION

  $1,169,900

  2022 · TO INVEST IN INNOVATIVE HEPATOLOGY RESEARCH AND IN THE PEOPLE WHO STUDY AND TREAT LIVER DISEASE; TO PROVIDE FUNDING FOR EMERGING LIVER SCHOLAR TRAVEL STIPENDS; PROVIDE FUNDING FOR TRAVEL AWARDS EXPENSES

• AMERICAN SOCIETY FOR INVESTIGATIVE PATHOLOGY

  $10,000

  2023 · PROVIDED SPONSORSHIP FOR THE 2024 SUMMER OF LIVER ACADEMY MEETING (SLAM) THAT TOOK PLACE IN CAPE CORAL, FLORIDA

Where these grants went next →

Grants received

• AMERICAN SOCIETY OF ADDICTION MEDICINE INC

  $17,573

  2024 · SUPPORT FOR SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES OPIOID STR

• AMERICAN SOCIETY OF ADDICTION MEDICINE INC

  $14,090

  2025 · SUPPORT FOR SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES OPIOID STR

• FORGOOD INC

  $6,802

  2022 · UNRESTRICTED

• DONOR ADVISED CHARITABLE GIVING

  $6,000

  2022 · HEALTH

Related organizations

From Schedule R Part II, where a filer lists the tax-exempt organizations it is related to by control. It does not record shared board members or money.

Other IRS files